Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Fc Receptor-Like 3 (FCRL3) (Middle Region) Peptid

FCRL3 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN5513186
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 15 bis 22 Werktagen

Kurzübersicht für Fc Receptor-Like 3 (FCRL3) (Middle Region) Peptid (ABIN5513186)

Target

FCRL3 (Fc Receptor-Like 3 (FCRL3))

Spezies

Human

Quelle

Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequenz

    RGSSLSDAVH VEFSPDWLIL QALHPVFEGD NVILRCQGKD NKNTHQKVYY

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-FCRL3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    FCRL3 (Fc Receptor-Like 3 (FCRL3))

    Hintergrund

    This gene encodes a member of the immunoglobulin receptor superfamily and is one of several Fc receptor-like glycoproteins clustered on the long arm of chromosome 1. The encoded protein contains immunoreceptor-tyrosine activation motifs and immunoreceptor-tyrosine inhibitory motifs in its cytoplasmic domain and may play a role in regulation of the immune system. Mutations in this gene have been associated with rheumatoid arthritis, autoimmune thyroid disease, and systemic lupus erythematosus.

    Protein Size: 199

    Gen-ID

    115352
Sie sind hier:
Chat with us!